Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 30 % of short-term debt in 2025; threshold 65 %.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2025.
Financials
Financial year 2025
URGO from Ukkel, company number BE0474339007, closed financial year 2025 with a result of € 237,137 after tax. For that financial year URGO recorded revenue of € 16.8 million and equity of € 2.4 million. Compared with financial year 2024, the result moved from € 46,643 to € 237,137. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 8, 2026.
€ 2.4 million
▲ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 237,137
▲ € 190,495 vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.8 million.
People and assets in 2025
27.9
▲ 5.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2.6 million
▲ 33% vs 2024
€ 91,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 29,633
▲ 50% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3.8 million
▲ 21% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 105 days on average.
€ 586,763
▲ 60% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 10,021,525 | € 12,357,620 | € 13,533,533 | € 16,808,093 | ▲ 24% |
| Profit after taxes | € -63,090 | € 257,156 | € 46,643 | € 237,137 | ▲ € 190,495 |
| Equity | € 1,818,320 | € 2,075,475 | € 2,122,118 | € 2,359,256 | ▲ 11% |
| Total debts | € 3,153,307 | € 2,978,183 | € 3,504,261 | € 14,742,112 | ▲ € 11.2 million |
| Cash | € 740,996 | € 281,822 | € 0 | - | |
| Retained profit | € 1,264,320 | € 1,521,476 | € 1,568,119 | € 1,805,256 | ▲ 15% |
| Balance sheet total | € 4,971,627 | € 5,053,658 | € 5,626,379 | € 17,101,368 | ▲ 204% |
| Employees (FTE) | 19 | 20.2 | 22.1 | 27.9 | ▲ 5.8 |
Key figures of URGO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to URGO?
What happened at URGO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Nathalie Chauvy stepped down as director. NBB
- Anne Martinet Durocher stepped down as director. NBB
- Antoine Bon stepped down as director. NBB
- Briac Le Lous stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 237,137 (▲ € 190,495 vs 2024). Source: NBB ↗
- Magali Daems became a director. NBB
- Gauthier Lauwers stepped down as director. NBB
- Nathalie Chauvy became a director. NBB
In short
From € 63,090 loss in 2022 to € 237,137 profit in 2025.
Paid € 369,949 in corporate taxes since 2022.
Best year ever: 2023, with € 257,156 profit.
Pays suppliers within 105 days on average.
A new publication or filing at URGO? We notify you, reason included.
Follow URGODatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind URGO is Magali Daems. The shares are held by Laboratoires Urgo Healhcare (100%) and Urgo Medical & Healthcare (0%). It owns 100% of Vista-Life Pharma itself.
Directors
According to the 2025 annual accounts
Magali Daems
Déléguée à la gestion journalière
since 2025
since 2022 · until 2025
since 2024 · until 2030
Antoine Bon
Director
Also active at: VISTA-LIFE pharma, ASSOCIATION EUROPEENNE DES SPECIALITES PHARMACEUTIQUES GRAND PUBLIC
since 2024 · until 2030
since 2024 · until 2030
since 2024 · until 2030
Shareholders
Laboratoires Urgo Healhcare
100%
Urgo Medical & Healthcare
0%
Participations
100%
Establishments
Establishment units
Physical locations of this company
Ruisbroeksesteenweg 76
1180 Ukkel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
All companies at this address →CAMERA and CO
€ -19,262 gross margin · 2025
THE STEADIMAKERS
€ 11,591 gross margin · 2025
CONNECTIS
€ 547,725 gross margin · 2025
MV STUDIO
€ 163,370 gross margin · 2025
LINK2LINK
€ 426,933 gross margin · 2024
+3 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
France Telecom - Orange, FR
Website info
Features
Security
Details
- Company number
- 0474.339.007
- VAT number
- BE 0474.339.007
- Registered office
- Ruisbroeksesteenweg 76, 1180 Ukkel
- Names & denominations
- URGO
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 15 March 2001
- Peppol
- Active · Active since 23 Nov 2025
- Contact
- urgo.be
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Handelsbemiddeling in de niet-gespecialiseerde groothandel
Handelsbemiddeling in goederen, algemeen assortiment
Vervaardiging van overige farmaceutische producten
Groothandel in reinigingsmiddelen
Groothandel in parfumerieën en cosmetica
Groothandel in behang en onderhoudsproducten
+1